Clinical care for opioid-using pregnant and postpartum women: The role of obstetric providers

American Journal of Obstetrics and Gynecology

Volumn 210, Issue 4, 2014, Pages 302-310

  Jones, Hendrée E ^a   Deppen, Krisanna ^b   Hudak, Mark L ^c   Leffert, Lisa ^d   McClelland, Carol ^a   Sahin, Leyla ^e   Starer, Jacquelyn ^f   Terplan, Mishka ^g   Thorp, John M ^a   Walsh, James ^h   Creanga, Andreea A ⁱ  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b GRANT MEDICAL CENTER   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^h SWEDISH MEDICAL CENTER   (United States)

ⁱ NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

opioid use; opioid agonist; substance use

Indexed keywords

BENZODIAZEPINE; BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; BUTORPHANOL; CODEINE; DIAMORPHINE; FENTANYL; ILLICIT DRUG; KETOROLAC; METHADONE; MORPHINE; NALBUPHINE; OPIATE; OPIATE AGONIST; OPIATE ANTAGONIST; OXYCODONE; OXYMORPHONE; PARACETAMOL; PHENYLEPHRINE; ZOLPIDEM;

ANALGESIA; ARTICLE; CLINICAL ASSESSMENT; DELIVERY; DOCTOR PATIENT RELATION; DRUG ABUSE; DRUG TRAFFIC; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; FOOD AND DRUG ADMINISTRATION; HEALTH CARE QUALITY; HUMAN; HYPERSENSITIVITY; INTRAPARTUM CARE; LABOR; MEDICAL SPECIALIST; OBSTETRIC PROCEDURE; OBSTETRICIAN; OFF LABEL DRUG USE; OPIATE ADDICTION; PAIN; PATIENT CONTROLLED ANALGESIA; PATIENT REFERRAL; POSTOPERATIVE PAIN; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; PUERPERIUM; RELAPSE; SCREENING TEST; TRUST; WITHDRAWAL SYNDROME;

OPIOID USE; OPIOID-AGONIST; SUBSTANCE USE;

ANALGESICS, OPIOID; BUPRENORPHINE; CONFIDENTIALITY; DOSE-RESPONSE RELATIONSHIP, DRUG; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; LABOR PAIN; LABOR, OBSTETRIC; MENTAL DISORDERS; METHADONE; NARCOTIC ANTAGONISTS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PAIN, POSTOPERATIVE; PHYSICIAN-PATIENT RELATIONS; POSTNATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL CARE; REFERRAL AND CONSULTATION; TRIAGE;

EID: 84897431634     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2013.10.010     Document Type: Article

References (47)

1. F.B. Earle Maternal opium habit and infant mortality Med Standard III 1888 2 4
2. S.W. Patrick, R.E. Schumacher, B.D. Benneyworth, E.E. Krans, J.M. McAllister, and M.M. Davis Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009 JAMA 307 2012 1934 1940
3. O.S. Ashley, M.E. Marsden, and T.M. Brady Effectiveness of substance abuse treatment programming for women: a review Am J Drug Alcohol Abuse 29 2003 19 53
4. Center for Substance Abuse Treatment Substance abuse treatment: addressing the specific needs of women: treatment improvement protocol (TIP) series 51; vol HHS publication no. (SMA) 09-4426 2009 Substance Abuse and Mental Health Services Administration Rockville, MD
5. S.S. Kim, S. Kaplowitz, and M.V. Johnston The effects of physician empathy on patient satisfaction and compliance Eval Health Prof 27 2004 237 251
6. J.T. Ptacek, and T.L. Eberhardt Breaking bad news: a review of the literature JAMA 276 1996 496 502
7. S.W. Mercer, and W.J. Reynolds Empathy and quality of care Br J Gen Pract 52 suppl 2002 S9 S12
8. M. Stewart, J.B. Brown, and A. Donner et al. The impact of patient-centered care on outcomes J Fam Pract 49 2000 796 804
9. M.A. Stewart Effective physician-patient communication and health outcomes: a review CMAJ 152 1995 1423 1433
10. E.A. Wagar, A.K. Stankovic, S. Raab, R.E. Nakhleh, and M.K. Walsh Specimen labeling errors: a Q-probes analysis of 147 clinical laboratories Arch Pathol Lab Med 132 2008 1617 1622
11. R.M. White, and M.L. Black Pain management testing reference 2007 AACC Press Washington, DC
12. J. Fitzsimmons, S. Tunis, D. Webster, J. Izes, R. Wapner, and L. Finnegan Pregnancy in a drug-abusing population Am J Drug Alcohol Abuse 12 1986 247 255
13. H.E. Jones, P.R. Martin, and S.H. Heil et al. Treatment of opioid-dependent pregnant women: clinical and research issues J Subst Abuse Treat 35 2008 245 259
14. H.E. Jones, S.H. Heil, and A. Baewert et al. Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review Addiction 107 suppl 1 2012 5 27
15. Food and Drug Administration. Guidance for Industry Providing Clinical Evidence of Effectiveness for Human Drugs and Biological Products. US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), May 1998, Clinical 6.
16. H.E. Jones, G. Fischer, and S.H. Heil et al. Maternal opioid treatment: human experimental research (MOTHER): approach, issues, and lessons learned Addiction 107 suppl 1 2012 28 35
17. I.O. Lund, G. Fischer, and G.K. Welle-Strand et al. A comparison of buprenorphine + naloxone to buprenorphine and methadone in the treatment of opioid dependence during pregnancy: maternal and neonatal outcomes Subst Abuse 7 2013 61 74
18. L.M. Jansson, J.A. Dipietro, A. Elko, and M. Velez Infant autonomic functioning and neonatal abstinence syndrome Drug Alcohol Depend 109 2010 198 204
19. A.L. Salisbury, M.G. Coyle, and K.E. O'Grady et al. Fetal assessment before and after dosing with buprenorphine or methadone Addiction 107 suppl 1 2012 36 44
20. J.L. Rementeria, and N.N. Nunag Narcotic withdrawal in pregnancy: stillbirth incidence with a case report Am J Obstet Gynecol 116 1973 11526
21. F.P. Zuspan, J.A. Gumpel, A. Mejia-Zelaya, J. Madden, and R. Davis Fetal stress from methadone withdrawal Am J Obstet Gynecol 122 1975 43 46
22. H.E. Jones, K.E. O'Grady, D. Malfi, and M. Tuten Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes Am J Addict 17 2008 372 386
23. J.S. Dashe, G.L. Jackson, and D.A. Olscher et al. Opioid detoxification in pregnancy Obstet Gynecol 92 1998 854
24. Health Insurance Portability and Accountability Act of 1996 (HIPAA). Pub. L. 104-191, 110 Stat. 1936, enacted Aug. 21, 1996.
25. S.R. Savage, and J. Schofferman Pharmacological therapies of pain in drug and alcohol addictions N.S. Miller, M.S. Gold, Pharmacological therapies for drug and alcohol addictions 1995 Marcel Dekker New York 373 409
26. B. Cassidy, and A.M. Cyna Challenges that opioid-dependent women present to the obstetric anaesthetist Anaesth Intensive Care 32 2004 494 501
27. D.P. Alford, P. Compton, and J.H. Samet Acute pain management for patients receiving maintenance methadone or buprenorphine therapy Ann Intern Med 144 2006 127 134
28. M. Meyer, G. Paranya, A. Keefer Norris, and D. Howard Intrapartum and postpartum analgesia for women maintained on buprenorphine during pregnancy Eur J Pain 14 2010 939 943
29. M. Meyer, K. Wagner, A. Benvenuto, D. Plante, and D. Howard Intrapartum and postpartum analgesia for women maintained on methadone during pregnancy Obstet Gynecol 110 2007 261 266
30. K. Ksouda, V. Bloch, and J. Dugarin et al. [When and how to detoxify clients from methadone maintenance treatment?] Presse Med 42 2013 e28 e36
31. B.A. Bailey, and R.J. Sokol Pregnancy and alcohol use: evidence and recommendations for prenatal care Clin Obstet Gynecol 51 2008 436 444
32. D.S. Svikis, and K. Reid-Quinones Screening and prevention of alcohol and drug use disorders in women Obstet Gynecol Clin North Am 30 2003 447 468
33. S.T. Diekman, R.L. Floyd, P. Decoufle, J. Schulkin, S.H. Ebrahim, and R.J. Sokol A survey of obstetrician-gynecologists on their patients' alcohol use during pregnancy Obstet Gynecol 95 2000 756 763
34. C. Oser, E. Biebel, M. Harris, E. Klein, and C. Leukefeld Gender differences in provider's use of a standardized screening tool for prenatal substance use J Addict Med 5 2011 36 42
35. R.J. Sokol, S.S. Martier, and J.W. Ager The T-ACE questions: practical prenatal detection of risk-drinking Am J Obstet Gynecol 160 1989 863 870
36. M. Russell New assessment tools for risk drinking during pregnancy: T-ACE, TWEAK, and others Alcohol Health Res World 18 1994 55 61
37. I.J. Chasnoff, A.M. Wells, R.F. McGourty, and L.K. Bailey Validation of the 4P's plus screen for substance use in pregnancy validation of the 4P's plus J Perinatol 27 2007 744 748
38. Center for Substance Abuse Prevention CSAP special report 13: maternal substance use assessment methods reference manual: a review of screening and clinical assessment instruments for examining maternal use of alcohol, tobacco, and other drugs 1993 US Department of Health and Human Services, Public Health Service, Substance Abuse and Mental Health Services Administration Rockville MD
39. Center for Substance Abuse Treatment. Buprenorphine. Available at: http://buprenorphine.samhsa.gov/index.html Accessed Sept. 30, 2013.
40. American Psychiatric Association. PCSS-B Training: an education resource for those treating patients with opioid use disorders. HOT TOPICS in buprenorphine treatment webinars. Available at: http://psychiatry.org/ pcssbwebinars. Accessed Sept. 30, 2013.
41. A.M. Holbrook, H.E. Jones, and S.H. Heil et al. Induction of pregnant women onto opioid-agonist maintenance medication: An analysis of withdrawal symptoms and study retention Drug Alcohol Depend 132 2013 329 334
42. Jones HE. Inducting and stabilizing opioid-dependent pregnant women on methadone or buprenorphine: current research and future treatment implications 2010. Available at: http://psychiatry.org/practice/professional-interests/ addiction-psychiatry/inducting-and-stabilizing-opioid-dependent-pregnant-women- on-methadone-or-buprenorphine-current-research-and-future-treatment- implications. Accessed Sept. 30, 2013.
43. Meyer MC. Buprenorphine treatment during pregnancy 2012. Available at: http://psychiatry.org/practice/professional-interests/addiction-psychiatry/ Buprenorphine-Treatment-During-Pregnancy. Accessed Sept. 30, 2013.
44. Center for Substance Abuse Treatment Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction: treatment improvement protocol (TIP) series 40. DHHS Publication No. (SMA) 04-3939 2004 Substance Abuse and Mental Health Services Administration Rockville, MD
45. J.E. Peachey, and H. Lei Assessment of opioid dependence with naloxone Br J Addict 83 1988 193 201
46. D.R. Wesson, and W. Ling The clinical opiate withdrawal scale (COWS) J Psychoactive Drugs 35 2003 253 259
47. L. Handelsman, K.J. Cochrane, M.J. Aronson, R. Ness, K.J. Rubinstein, and P.D. Kanof Two new rating scales for opiate withdrawal Am J Drug Alcohol Abuse 13 1987 293 308